Base
Notice2024-022982024-02-06

Xanthan Gum From the People's Republic of China: Final Results of Antidumping Duty Administrative Review, Partial Rescission of the Antidumping Duty Administrative Review, and Final Determination of No Shipments; 2021-2022

Commerce Department, International Trade Administration

Abstract

The U.S. Department of Commerce (Commerce) determines that Fufeng Biotechnologies Co., Ltd. (aka Inner Mongolia Fufeng Biotechnologies Co., Ltd.), Shandong Fufeng Fermentation Co., Ltd., and Xinjiang Fufeng Biotechnologies Co., Ltd. (collectively, Fufeng) and Meihua Group International Trading (Hong Kong) Limited, Langfang Meihua Biotechnology Co., Ltd., and Xinjiang Meihua Amino Acid Co., Ltd. (collectively, Meihua) sold xanthan gum from the People's Republic of China (China) at less than normal value during the period of review (POR), July 1, 2021, through June 30, 2022. Additionally, we find that Jianlong Biotechnology Co., Ltd. (formerly, Inner Mongolia Jianlong Biochemical Co., Ltd) (Jianlong), Deosen Biochemical (Ordos) Ltd./ Deosen Biochemical Ltd. (collectively, Deosen), and CP Kelco (Shandong) Biological Company Limited (CP Kelco (Shandong)) have each demonstrated that they are eligible for a separate rate. Further, Commerce is rescinding this review with respect to Deosen USA, Inc. Commerce also determines that three companies for which we initiated reviews had no shipments during the POR.

Action & Dates

Dates
Applicable February 6, 2024.

Document Excerpt

Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Commerce International Trade Administration [A-570-985] AGENCY: Enforcement and Compliance, International Trade Administration, Department of Commerce. SUMMARY: The U.S. Department of Commerce (Commerce) determines that Fufeng Biotechnologies Co., Ltd. (aka Inner Mongolia Fufeng Biotechnologies Co., Ltd.), Shandong Fufeng Fermentation Co., Ltd., and Xinjiang Fufeng Biotechnologies Co., Ltd. (collectively, Fufeng) and Meihua Group International Trading (Hong Kong) Limited, Langfang Meihua Biotechnology Co., Ltd., and Xinjiang Meihua Amino Acid Co., Ltd. (collectively, Meihua) sold xanthan gum from the People's Republic of China (China) at less than normal value during the period of review (POR), July 1, 2021, through June 30, 2022. Additionally, we find that Jianlong Biotechnology Co., Ltd. (formerly, Inner Mongolia Jianlong Biochemical Co., Ltd) (Jianlong), Deosen Biochemical (Ordos) Ltd./Deosen Biochemical Ltd. (collectively, Deosen), and CP Kelco (Shandong) Biological Company Limited (CP Kelco (Shandong)) have each demonstrated that they are eligible for a separate rate. Further, Commerce is rescinding this review with respect to Deosen USA, Inc. Commerce also determines that three companies for which we initiated reviews had no shipments during the POR. DATES: Applicable February 6, 2024. FOR FURTHER INFORMATION CONTACT: Reginald Anadio, AD/CVD Operations, Office IV, Enforcement and Compliance, International Trade Administration, U.S. Department of Commerce,

Read full document on FederalRegister.gov →

Related Documents

Other Federal Register documents from the same docket.

Full Document

Citation: 89 FR 8165